1. Home
  2. GBCI vs LEGN Comparison

GBCI vs LEGN Comparison

Compare GBCI & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glacier Bancorp Inc.

GBCI

Glacier Bancorp Inc.

N/A

Current Price

$44.79

Market Cap

6.3B

Sector

Finance

ML Signal

N/A

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

N/A

Current Price

$20.23

Market Cap

5.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GBCI
LEGN
Founded
1955
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.9B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
GBCI
LEGN
Price
$44.79
$20.23
Analyst Decision
Strong Buy
Buy
Analyst Count
5
14
Target Price
$53.60
$63.46
AVG Volume (30 Days)
952.6K
1.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.95%
N/A
EPS Growth
18.45
N/A
EPS
1.99
N/A
Revenue
N/A
N/A
Revenue This Year
$31.62
$46.27
Revenue Next Year
$8.37
$28.77
P/E Ratio
$22.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.76
$16.24
52 Week High
$53.99
$45.30

Technical Indicators

Market Signals
Indicator
GBCI
LEGN
Relative Strength Index (RSI) 37.81 60.43
Support Level $43.01 $16.24
Resistance Level $46.61 $21.58
Average True Range (ATR) 1.62 0.91
MACD -0.44 0.25
Stochastic Oscillator 30.73 68.20

Price Performance

Historical Comparison
GBCI
LEGN

About GBCI Glacier Bancorp Inc.

Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: